Merck & Co. Inc. (MRK)

0.73%
$0.45
$62.42
21:27 22/08/17
$62.42
21:27 22/08/17
DAILY VARIATION
0.73%
$0.45
VOLUME
5,432,129
DATA
52 Week High
$66.58
52 Week Low
$58.43
Shares Issued
2,727.35m
Market Cap
$170,241.45m
RiskGrade
n/a
Beta
0.64
MENU

Merck & Co. Inc. Overview

US drugmaker, Merck & Co, is a leading global research-driven pharmaceutical products and services company. The company discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly and through its joint ventures. Its products, generally sold by prescription, include therapeutic and preventive agents for the treatment of human disorders and animal health supplies. The company’s products are sold, primarily, to drug wholesalers and retailers, hospitals, clinics, government agencies and managed healthcare providers, such as health maintenance organisations and other institutions.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 3.0% 3.0%
Div Cover 0.8 2.1
Op Mrgn 11.9% 33.6%
ROCE 15.7%
Latest F'cast
P/E 44.0 1,588.9
PEG -4.3 0.1
Pr/Revenue 4.3 4.2
Pr/Book 4.2
Latest F'cast
Revenue 0.8% 0.0%
PBT -13.7% n/a
EPS -10.1% 0.0%
DPS 2.2% 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2012-12-31 47,267.00 8,739.00 203.00¢ 20.2 -41.1 -0% 169.00¢ 4.1%
2013-12-31 44,033.00 5,545.00 149.00¢ 33.6 -1.3 -27% 173.00¢ 3.5%
2014-12-31 42,237.00 17,283.00 412.00¢ 13.8 0.1 177% 177.00¢ 3.1%
2015-12-31 39,498.00 5,401.00 158.00¢ 33.4 -0.5 -62% 181.00¢ 3.4%
2016-12-31 39,807.00 4,659.00 142.00¢ 41.5 -4.1 -10% 185.00¢ 3.1%

Forecast

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 40,295.45 13,535.92 386.67c 1,588.9 9.2 172% 188.28c 3.1%
2018-12-31 41,426.35 14,504.14 420.36c 1,450.2 166.4 9% 193.62c 3.1%

Regulatory News

No results found

Newspaper Links

No results found